PCMA Statement Following The 2024 Election

(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement from JC Scott, President and CEO of PCMA:

“PCMA congratulates President-elect Donald Trump, Vice President-elect JD Vance and newly elected Members of Congress on their victories in the 2024 election.

“America’s pharmacy benefit managers (PBMs) look forward to working with the Trump Administration and Members on both sides of the aisle in the 119th Congress to achieve more affordable prescription drugs for all Americans.

“To make progress on drug affordability, policymakers have to start by addressing the prices set by drug companies and misuse of the patent system that blocks market-based competition. Promoting greater competition, along with protecting critical choice and flexibility for employers, will lead to lower cost prescription drugs. We stand ready to partner with federal and state policymakers to deliver for American patients.”

###

PCMA is the national association representing America’s pharmacy benefit companies. Pharmacy benefit companies are working every day to secure savings, enable better health outcomes, and support access to quality prescription drug coverage for more than 275 million patients.